These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 25464400)

  • 1. Ivabradine for rate control in atrial fibrillation.
    Kosiuk J; Oebel S; John S; Hilbert S; Hindricks G; Bollmann A
    Int J Cardiol; 2015 Jan; 179():27-8. PubMed ID: 25464400
    [No Abstract]   [Full Text] [Related]  

  • 2. Ivabradine reduced ventricular rate in patients with non-paroxysmal atrial fibrillation.
    Wongcharoen W; Ruttanaphol A; Gunaparn S; Phrommintikul A
    Int J Cardiol; 2016 Dec; 224():252-255. PubMed ID: 27661415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Might ivabradine be useful in permanent atrial fibrillation?
    Moubarak G; Logeart D; Cazeau S; Cohen Solal A
    Int J Cardiol; 2014 Jul; 175(1):187-8. PubMed ID: 24814540
    [No Abstract]   [Full Text] [Related]  

  • 4. Ivabradine and atrial fibrillation: what should we tell our patients?
    Cowie MR
    Heart; 2014 Oct; 100(19):1487-8. PubMed ID: 24986893
    [No Abstract]   [Full Text] [Related]  

  • 5. Addition of ivabradine to betablockers in patients with atrial fibrillation: Effects on heart rate and exercise tolerance.
    Caminiti G; Fossati C; Rosano G; Volterrani M
    Int J Cardiol; 2016 Jan; 202():73-4. PubMed ID: 26386926
    [No Abstract]   [Full Text] [Related]  

  • 6. Combined actions of ivabradine and ranolazine reduce ventricular rate during atrial fibrillation.
    Verrier RL; Silva AF; Bonatti R; Batatinha JA; Nearing BD; Liu G; Rajamani S; Zeng D; Belardinelli L
    J Cardiovasc Electrophysiol; 2015 Mar; 26(3):329-35. PubMed ID: 25346368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart rate lowering for coronary CTA with Ivabradine in atrial fibrillation.
    Agakishiev D; Arriola-Montenegro J; Tandon R; Markowitz J; Kazmirczak F; Nijjar PS
    J Cardiovasc Comput Tomogr; 2024; 18(1):109-110. PubMed ID: 37867126
    [No Abstract]   [Full Text] [Related]  

  • 8. Emerging role of ivabradine for rate control in atrial fibrillation.
    Turley SL; Francis KE; Lowe DK; Cahoon WD
    Ther Adv Cardiovasc Dis; 2016 Dec; 10(6):348-352. PubMed ID: 27659287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ivabradine and atrial fibrillation: A double-edged sword.
    Lu Y; Li K; Liu XS; Zhang N; Li G; Liu T
    Int J Cardiol; 2016 Nov; 223():182-185. PubMed ID: 27541651
    [No Abstract]   [Full Text] [Related]  

  • 10. Need for further studies on ivabradine in patients with persistent atrial fibrillation.
    Kosiuk J; Lindemann F; Hindricks G; Bollmann A
    Int J Cardiol; 2016 Nov; 223():915-916. PubMed ID: 27589039
    [No Abstract]   [Full Text] [Related]  

  • 11. Ivabradine as an Alternative to AV Node Ablation in a Patient With Permanent Atrial Fibrillation.
    Fontenla A; Villagraz L; de Juan J; Lozano Á; Giacoman S; López-Gil M
    Rev Esp Cardiol (Engl Ed); 2017 Nov; 70(11):1019-1020. PubMed ID: 28522303
    [No Abstract]   [Full Text] [Related]  

  • 12. Ivabradine in heart failure--no paradigm SHIFT…yet.
    Teerlink JR
    Lancet; 2010 Sep; 376(9744):847-9. PubMed ID: 20801501
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of ivabradine on heart rate and left ventricular function in healthy cats and cats with hypertrophic cardiomyopathy.
    Riesen SC; Schober KE; Smith DN; Otoni CC; Li X; Bonagura JD
    Am J Vet Res; 2012 Feb; 73(2):202-12. PubMed ID: 22280379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the heart rate-lowering action of ivabradine, a selective I(f) current inhibitor.
    Borer JS; Le Heuzey JY
    Am J Ther; 2008; 15(5):461-73. PubMed ID: 18806523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metoprolol vs ivabradine in patients with mitral stenosis.
    Ergün G; Doğan V; Başaran Ö; Biteker M
    Int J Cardiol; 2016 Nov; 223():108. PubMed ID: 27537731
    [No Abstract]   [Full Text] [Related]  

  • 16. Innovation in coronary artery disease and heart failure: clinical benefits of pure heart rate reduction with ivabradine.
    Canet E; Lerebours G; Vilaine JP
    Ann N Y Acad Sci; 2011 Mar; 1222():90-9. PubMed ID: 21434947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart Rate Lowering for Coronary CTA with Ivabradine in End-Stage Liver Disease.
    Tandon R; Agakishiev D; Freese RL; Thompson J; Nijjar PS
    Radiol Cardiothorac Imaging; 2024 Jun; 6(3):e230402. PubMed ID: 38814188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Funny and late: targeting currents governing heart rate in atrial fibrillation.
    Daniels JD; Hill JA
    J Cardiovasc Electrophysiol; 2015 Mar; 26(3):336-8. PubMed ID: 25511517
    [No Abstract]   [Full Text] [Related]  

  • 19. Ivabradine (Corlanor) for Heart Failure.
    Davis K; Dietrich E
    Am Fam Physician; 2016 Apr; 93(8):682-4. PubMed ID: 27175841
    [No Abstract]   [Full Text] [Related]  

  • 20. Ivabradine: beyond heart rate control.
    Riccioni G; Vitulano N; D'Orazio N
    Adv Ther; 2009 Jan; 26(1):12-24. PubMed ID: 19165437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.